Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E14.65 EPS (ttm)2.72 Insider Own0.03% Shs Outstand5.54B Perf Week-1.95%
Market Cap220.69B Forward P/E13.93 EPS next Y2.86 Insider Trans0.21% Shs Float5.53B Perf Month1.27%
Income15.42B PEG3.53 EPS next Q0.57 Inst Own73.00% Short Float1.03% Perf Quarter8.29%
Sales53.04B P/S4.16 EPS this Y-11.90% Inst Trans-0.16% Short Ratio2.90 Perf Half Y-6.68%
Book/sh11.74 P/B3.39 EPS next Y-3.32% ROA10.10% Target Price42.33 Perf Year-2.76%
Cash/sh1.64 P/C24.29 EPS next 5Y4.15% ROE26.30% 52W Range33.97 - 44.56 Perf YTD1.63%
Dividend1.52 P/FCF65.80 EPS past 5Y1.00% ROI10.20% 52W High-10.64% Beta0.67
Dividend %3.82% Quick Ratio0.70 Sales past 5Y0.80% Gross Margin80.30% 52W Low17.22% ATR0.59
Employees92400 Current Ratio0.90 Sales Q/Q-4.60% Oper. Margin36.70% RSI (14)53.33 Volatility1.67% 1.36%
OptionableYes Debt/Eq0.81 EPS Q/Q98.20% Profit Margin30.60% Rel Volume1.66 Prev Close40.71
ShortableYes LT Debt/Eq0.55 EarningsJan 28 BMO Payout48.70% Avg Volume19.69M Price39.82
Recom2.50 SMA200.59% SMA502.88% SMA2001.70% Volume32,394,392 Change-2.19%
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jan-27-20 06:30AM  Pfizer Reports Earnings Tomorrow. Heres What to Expect. Barrons.com
Jan-26-20 11:59AM  The Dow is about to face its stiffest test in years MarketWatch
10:23AM  The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes Benzinga
07:43AM  Pfizer Inc. (NYSE:PFE) Looks Interesting, And It's About To Pay A Dividend Simply Wall St.
12:00AM  Why big pharma sees a remedy in data and AI Financial Times
Jan-24-20 03:16PM  Dow Inc., Merck share losses contribute to Dow's 133-point drop MarketWatch
01:50PM  New partnership aims to ease surging generic drug costs by making its own Yahoo Finance
11:05AM  What Lies Ahead for Healthcare ETFs in Q4 Earnings? Zacks
10:45AM  Dow Inc., Pfizer share losses lead Dow's 29-point drop MarketWatch
09:54AM  Pharma Stock Roundup: J&J's Mixed Q4, Roche & Novartis' New Drugs Approval in EU Zacks
09:31AM  Will Pfizer's (PFE) BioPharma Unit Boost Its Q4 Earnings? Zacks
Jan-23-20 06:00PM  Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments GuruFocus.com
12:13PM  Drug giant taps U of L for first-of-its kind research center American City Business Journals
10:00AM  Pfizer Vaccines Launches Global Centers of Excellence Network to Conduct Real-World Research on Vaccine-Preventable Diseases Affecting Adults Business Wire
09:12AM  The Zacks Analyst Blog Highlights: Pfizer, Wells Fargo, SAP, salesforce.com and Eli Lilly Zacks
08:46AM  Pfizer (PFE) Q4 Earnings Coming Up: What's in the Cards? Zacks
08:13AM  Primary Drivers of the Chinese Economy Investopedia
06:45AM  Pfizers Greenstone and Digital Mens Health Clinic Roman Collaborate to Offer Patients Remote Access to the Only FDA-Approved Authorized Generic Version of Viagra® (sildenafil citrate) Business Wire
Jan-22-20 05:45PM  Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know Zacks
12:41PM  Top Stock Analyst Reports for Pfizer, Wells Fargo & SAP Zacks
09:22AM  Glaxo's Multiple Myeloma Candidate Gets FDA's Priority Review Zacks
Jan-21-20 08:00AM  Pharma firms not making enough progress against superbugs - report Reuters
Jan-20-20 09:03AM  AstraZeneca Announces Positive FDA Updates on Cancer Drugs Zacks
Jan-17-20 05:40PM  Pharma and Biotech Arent Worried About Democratic Candidates Attacks Against Drugmakers Barrons.com
07:47AM  Novo Nordisk's Ozempic Gets FDA Nod for CV Risk Reduction Zacks
06:30AM  Why Amarin Stock Is Poised for a Healthy 2020 InvestorPlace
Jan-16-20 10:32AM  US Indexes Close Higher Wednesday With China Trade Deal Signing GuruFocus.com
08:52AM  Bristol-Myers' Opdivo-Yervoy sBLA for NSCLC Accepted by FDA Zacks
04:08AM  Glaxo, Pfizer Executives Out of Step on Consumer Units Future Bloomberg
03:01AM  Influencers Transcript: Robert F. Kennedy, Jr., January 16, 2020 Yahoo Finance
Jan-15-20 11:00PM  Hedge fund veteran looks to cash in on biotech boom Financial Times
10:48AM  UnitedHealth, Pfizer share gains lead Dow's 150-point climb MarketWatch
10:18AM  Lilly to Launch Cheaper Versions of Humalog KwikPen Insulins Zacks
09:47AM  Dow's 75-point climb led by gains in UnitedHealth, Pfizer stocks MarketWatch
09:07AM  Is Pfizer Inc. (NYSE:PFE) Trading At A 49% Discount? Simply Wall St.
08:00AM  3 Large-Cap Dividend Stocks to Buy Now for Your 2020 Portfolio Zacks
03:08AM  Pfizer Eyes IPO of Glaxo Consumer Venture in 3 to 4 Years Bloomberg
Jan-14-20 04:21PM  Dow Jones Today: JPMorgan Gives Dow a Lift as Stocks Falter Near Highs InvestorPlace
01:04PM  Pharmacia Corporation (Old Monsanto) -- Moody's announces completion of a periodic review of ratings of Pfizer Inc. Moody's
12:38PM  Charting a bullish 2020 start: S&P 500 extends break to record territory MarketWatch
11:12AM  JPMorgan Chase, Walgreens Boots share gains contribute to Dow's nearly 75-point climb MarketWatch
11:00AM  7 Dividend ETFs That Offer Growth in 2020 Zacks
09:55AM  Biogen Acquires Early-Stage CNS Drug From Pfizer for $75M Zacks
08:30AM  Insilico enters into research collaboration with Pfizer Inc. to explore novel data and artificial intelligence system for potential therapeutic targets PR Newswire
Jan-13-20 05:45PM  Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know Zacks
01:31PM  Top Pharmaceutical Stocks for Q1 2020 Investopedia
11:30AM  Is Pfizer (PFE) Stock Outpacing Its Medical Peers This Year? Zacks
10:26AM  Glaxo Files Marketing Application for Fostemsavir in Europe Zacks
09:46AM  In time for biotech's biggest conference, Union Square costs climb American City Business Journals
09:14AM  Nektar Up 25% as Bristol-Myers Expands Bempeg Collaboration Zacks
08:46AM  Benzinga Pro's Top 5 Stocks To Watch For Mon., Jan. 13, 2020: WCC, LULU, XLF, TEAM, BIIB Benzinga
07:51AM  Biogen to buy from Pfizer an asset to develop into potential Alzheimer's, Parkinson's treatments MarketWatch
07:30AM  Biogen to Acquire Novel Clinical Stage Asset with Application in Alzheimers Disease and Parkinsons Disease from Pfizer Inc. GlobeNewswire
06:00AM  Axsome Therapeutics Enters into Exclusive License Agreement with Pfizer Inc. for Pfizers Reboxetine Clinical and Nonclinical Data and for New Phase 3 Esreboxetine Product Candidate GlobeNewswire
Jan-10-20 04:33PM  Eli Lilly Made a Deal for Dermira. The Biotechs Stock Price Shows Investors Expect More. Barrons.com
04:30PM  Dow Jones Today: Stocks Pinched by Jobs Disappointment InvestorPlace
03:56PM  Stock Market Gives Back Early Gains After Weakish Jobs Data; These Chinese Growth Stocks Continue To Rise Investor's Business Daily
03:43PM  California may become first state to sell its own prescription drugs Yahoo Finance Video
02:22PM  Pfizer Offers a Strong Combination of Growth and Income GuruFocus.com
01:34PM  Dogs of the Dow 2020: 10 Dividend Stocks to Watch Kiplinger
10:59AM  All Bets Are Off for Amarin Stock InvestorPlace
Jan-09-20 01:31PM  Pfizer Stock Has No Momentum in Its Business or on the Charts InvestorPlace
10:05AM  Viatris Will Be the New Kid in Generic Drugs. Dont Expect the Stock to Surge, Analyst Says. Barrons.com
09:55AM  Waltham's Amag Pharma replacing CEO, cutting two products American City Business Journals
08:43AM  Merck's Keytruda Gets FDA Nod for High-Risk Bladder Cancer Zacks
08:00AM  eFFECTOR Enters Into Agreement with Pfizer Inc. to Develop Novel First-in-Class Inhibitors of eIF4E to Treat Multiple Cancer Types GlobeNewswire
05:00AM  Top Picks 2020- Pfizer PFE MoneyShow
Jan-08-20 05:53PM  Among Top 5 Pharma Companies, Pfizer Was the Worst Performer in 2019 GuruFocus.com
08:13AM  3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2020 Zacks
Jan-07-20 03:49PM  5 Top Stock Trades for Wednesday: MU, SQ, WMT InvestorPlace
11:00AM  Top Health Care Stocks for January 2020 Investopedia
10:06AM  Urbem's 'Quality Strategy' Series: The Installed Base GuruFocus.com
10:02AM  Merck's Keytruda Misses One of Two Goals in Lung Cancer Study Zacks
10:00AM  Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire
09:42AM  Pfizer/Merck KGaA's Bavencio Positive in Bladder Cancer Study Zacks
Jan-06-20 05:45PM  Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know Zacks
03:14PM  Dogs of the Dow 2020: 10 Dividend Stocks to Watch Kiplinger
03:02PM  Md. biotech outlines path for blood cancer drug, including in China American City Business Journals
01:52PM  New antibiotics struggle to generate sales, pharma companies hurt Yahoo Finance Video
09:00AM  Pfizer Stock Is A Top Pharma Company But Should You Buy It? Investor's Business Daily
07:00AM  BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma PR Newswire
Jan-05-20 04:52PM  The Sectors We Try to Avoid and Why GuruFocus.com
Jan-04-20 07:30PM  These 2 stocks dominated S&P 500 returns in 2019 and the decade MarketWatch
07:30AM  Pfizer Bought a Penny Biotech Stock Just Before It Doubled Barrons.com
Jan-03-20 04:25PM  Dow Jones Today: Geopolitical Tensions Lead to a Tense Day for Stocks InvestorPlace
04:15PM  Dow Jones Recovers After 345-Point Drop; Defense Stocks Soar As Facebook, Alphabet Hit New Highs Investor's Business Daily
01:38PM  After Lackluster 2019, Pfizer Stock Could Rebound in 2020 InvestorPlace
10:04AM  Aerie's (AERI) Application for Roclanda Accepted in Europe Zacks
09:58AM  Horizon Therapeutics' Stock Up in a Year on Pipeline Progress Zacks
09:19AM  Glaxo (GSK) Shares Continue to Witness Upside: Here's Why Zacks
09:00AM  AbbVie Stock Is Poised To Become A Top Pharma But Should You Buy It? Investor's Business Daily
08:20AM  The Zacks Analyst Blog Highlights: Pfizer, BP, Fidelity National Information Services, Deere & Company and Equity Residential Zacks
01:15AM  Pfizer and other drugmakers start 2020 with price rises Financial Times
Jan-02-20 11:23AM  Top Stock Reports for Pfizer, BP & Fidelity National Information Services Zacks
10:08AM  Drug-Price Increases Show Business as Usual Despite Public Pressure Barrons.com
09:37AM  3 Reasons Why You Should Buy Eli Lilly (LLY) Stock in 2020 Zacks
08:11AM  Dow Jones 3 Stock Market Losers Start 2020 With a Hangover TheStreet.com
07:48AM  The Zacks Analyst Blog Highlights: Exxon Mobil, Verizon, Chevron, Pfizer and 3M Zacks
Dec-31-19 05:45PM  Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know Zacks
04:20PM  Here Are The Top 5 Dow Jones Laggards This Year And Boeing Isn't The Worst Investor's Business Daily
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Merck & Co., Inc. and Eli Lilly & Company, Merck KGaA, Nektar Therapeutics, Syapse, Inc., eFFECTOR Therapeutics, Inc., and Insilico Medicine, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PFIZER INC10% OwnerSep 17Buy18.0050,000900,0004,593,847Sep 19 04:19 PM
Gottlieb ScottDirectorAug 23Buy34.723,000104,1603,000Aug 26 09:27 AM
DAMELIO FRANK AExecutive Vice PresidentJul 02Sale44.09153,1846,753,385337,392Jul 03 04:06 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentJun 20Sale44.0030,0001,320,00080,094Jun 21 04:08 PM
PFIZER INC10% OwnerMay 13Buy17.0050,000850,0003,249,973May 14 07:34 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentApr 01Sale42.8315,000642,503110,094Apr 02 03:05 PM
JOHNSON RADY AExecutive Vice PresidentMar 15Sale41.138,700357,83159,797Mar 18 06:37 PM
Dolsten MikaelPresident R&DMar 04Sale43.5249,0822,136,293289,126Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentMar 04Sale42.9815,002644,79814,920Mar 05 04:55 PM
READ IAN CExecutive ChairmanMar 04Sale43.2950,7882,198,4741,639,280Mar 06 04:03 PM
READ IAN CExecutive ChairmanMar 04Sale43.17530,07822,882,7021,109,202Mar 06 04:03 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.268,725377,444172,094Mar 06 03:29 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.1463,9982,760,698108,096Mar 06 03:29 PM
Dolsten MikaelPresident R&DMar 01Option Exercise31.34106,1913,328,057438,679Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Sale43.56100,4714,376,852338,208Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 27Option Exercise32.2319,297621,94245,049Mar 01 07:47 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise32.2385,7632,764,141228,743Mar 01 07:47 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise32.23154,3744,975,474441,923Mar 01 07:47 PM
GOETTLER MICHAELGroup PresidentFeb 27Option Exercise32.2330,017967,44848,652Mar 01 07:37 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise32.2311,792380,05623,635Mar 01 07:37 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise32.2330,017967,44881,341Mar 01 07:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise32.2364,3222,073,098123,145Mar 01 07:37 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 27Option Exercise32.2381,4752,625,939416,278Mar 01 07:37 PM
BOURLA ALBERTChief Executive OfficerFeb 27Option Exercise32.2364,3222,073,098331,982Mar 01 07:29 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 27Option Exercise32.2325,729829,246121,743Mar 01 07:29 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise32.23182,2475,873,821588,177Mar 01 07:29 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0343,724919,516312,403Feb 26 07:45 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0318,004378,62461,182Feb 26 07:45 PM
BOURLA ALBERTChief Executive OfficerFeb 23Option Exercise21.0336,008757,248191,438Feb 26 07:45 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.0387,4491,839,052388,024Feb 26 07:45 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03185,1853,894,441522,576Feb 26 07:45 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.0397,7372,055,409205,833Feb 26 07:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0343,724919,51683,781Feb 26 07:45 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 23Option Exercise21.0341,615875,163144,164Feb 26 07:10 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0330,864649,070115,139Feb 26 07:10 PM
ROGERS DAWNExecutive Vice PresidentFeb 23Option Exercise21.0319,290405,66937,638Feb 26 07:10 PM
GOETTLER MICHAELGroup PresidentFeb 23Option Exercise21.0319,290405,66931,507Feb 26 07:11 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 01Sale42.755,000213,75040,057Feb 01 07:21 PM
Dolsten MikaelPresident R&DJan 31Option Exercise29.78125,9683,751,425362,051Feb 01 07:28 PM
LANKLER DOUGLAS MExecutive Vice PresidentJan 30Sale41.1938,8001,598,07145,057Feb 01 07:21 PM